Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report
Sehe-Dong Lee, Hye-Jeong Kim, Seung-Jae Hwang, Yoon-Jung Kim, Seung-Hyun Nam, Bong-Seog Kim
Korean J Intern Med. 2007;22(2):109-112. Published online 2007 Jun 30 DOI: https://doi.org/10.3904/kjim.2007.22.2.109
Citations to this article as recorded by 
Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome
Yan Lou, Qian Wang, Jinqi Zheng, Haihong Hu, Lin Liu, Dongsheng Hong, Su Zeng
Chemical Research in Toxicology.2016; 29(10): 1591. CrossRef
Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer
Claire Marie Reyes-Habito, Ellen K. Roh
Journal of the American Academy of Dermatology.2014; 71(2): 203.e1. CrossRef
Effective management of adverse effects while on oral chemotherapy: implications for nursing practice
K. HARROLD
European Journal of Cancer Care.2010; 19: 12. CrossRef
Hand-Foot syndrome induced by sorafenib, a multitargeted tyrosine kinase inhibitor, in a patient with advanced renal cell carcinoma
Seung Hyun Lee, Sung Hun Noh, Sun Young Kim, Kyu Yun Jang, Pyoung Han Hwang
Korean Journal of Pediatrics.2009; 52(1): 119. CrossRef
Hand-Foot Syndrome With Sclerodactyly-Like Changes in a Patient Treated With Capecitabine
Felicidade Trindade, Rosario Haro, Maria Carmen Fariña, Luis Requena
The American Journal of Dermatopathology.2008; 30(2): 172. CrossRef
Palmar–Plantar Hyperpigmentation with Capecitabine in Adjuvant Colon Cancer
Michael M. Vickers, Jacob C. Easaw
Journal of Gastrointestinal Cancer.2008; 39(1-4): 141. CrossRef